Home Metabolism FAAH inhibitor LY-2183240 For research use only.

LY-2183240

LY-2183240 is a potent, covalent inhibitor of the EC-degrading enzyme fatty acid amide hydrolase (FAAH). LY-2183240 disrupts the cellular uptake of the lipid endocannabinoid (EC) anandamide and promote analgesia in vivo. LY-2183240 is also an inhibitor of monoacylgylcerol lipase (MGL).

LY-2183240 Chemical Structure

LY-2183240 Chemical Structure

CAS No. 874902-19-9

Purity & Quality Control

LY-2183240 Related Products

Signaling Pathway

FAAH Signaling Pathways

FAAH Signaling Pathway

Biological Activity

Description LY-2183240 is a potent, covalent inhibitor of the EC-degrading enzyme fatty acid amide hydrolase (FAAH). LY-2183240 disrupts the cellular uptake of the lipid endocannabinoid (EC) anandamide and promote analgesia in vivo. LY-2183240 is also an inhibitor of monoacylgylcerol lipase (MGL).
Targets
FAAH [1] MGL [2]
In vitro
In vitro

LY2183240 inhibits anandamide uptake in live cell with IC50 of 0.27 nM. [1] LY2183240 inactivates FAAH by carbamylation of the enzyme’s serine nucleophile. LY2183240 also inhibits KIAA1363, α/β-hydrolase 6 (Abh6) and monoacylglycerol lipase (MAG lipase) expressed in COS-7 cells with IC50 of 8.3, 0.09 and 5.3 nM, respectively. [2]
Cell Research Cell lines mouse brain membranes
Concentrations 0.001-10 μM
Incubation Time 10 min
Method

FAAH activity is measured in mouse brain membranes in the presence of varying concentrations of inhibitor. Brain membranes (1 mg/mL) from FAAH (-/-) mice are used as a control. Briefly, varying concentrations of LY2183240 (1 μL, 100×stock in DMSO added to provide 0.001-10 μM final concentration) are preincubated with brain membranes (1 mg/mL in 50 mM Tris, pH 8, 94 μL) for 10 min.
In Vivo
In vivo

LY2183240 (i.p.) results in a dose-dependent increase in anandamide concentrations in rat cerebellum with ED50 of 1.37 mg/kg. LY2183240 (i.p.) dose-dependently attenuates formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms. [1] LY2183240 (10 mg/kg, i.p.) treatment for 90 min inactivates FAAH (100% inhibited), Abh6 (>90% inhibited), and MAG lipase (>60% inhibited) in brain tissue. [2] LY2183240 shows beneficiation on fear-potentiated startle (FPS) and alcohol-seeking behaviors (HAP) in mice selectively bred for high alcohol preference. Repeated administration of LY2183240 (30 mg/kg) reduces the expression of FPS in HAP mice when given prior to a second FPS test 48 h after fear conditioning. Both the 10 and 30 mg/kg doses of LY2183240 enhances the expression of alcohol-induced conditioned place preference and this effect persisted in the absence of the drug. [3]
Animal Research Animal Models male wild type or FAAH (-/-) C57Bl/6 mice
Dosages 10 mg/kg
Administration IP

Chemical Information & Solubility

Molecular Weight 307.35 Formula

C17H17N5O
CAS No. 874902-19-9 SDF --
Smiles CN(C)C(=O)[N]1N=NN=C1CC2=CC=C(C=C2)C3=CC=CC=C3
Storage (From the date of receipt) 3 years-21°C powder

In vitro
Batch:

DMSO : 61 mg/mL ( (198.47 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 61 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy LY-2183240 | LY-2183240 supplier | purchase LY-2183240 | LY-2183240 cost | LY-2183240 manufacturer | order LY-2183240 | LY-2183240 distributor